Try a new search

Format these results:

Searched for:

in-biosketch:true

person:fishej03

Total Results:

69


Morbidity and mortality in early term infants with meconium aspiration and/or persistent pulmonary hypertension of newborn requiring ecmo [Meeting Abstract]

Verma, S; Choi, B H; Toy, B; Cicalese, E; Dapul, H; Chopra, A; Fisher, J
Infants with meconium aspiration syndrome (MAS) and/or persistent pulmonary hypertension of newborn (PPHN) have the most favorable outcomes among infants requiring extracorporeal membrane oxygenation (ECMO). Early term (ET) infants have been shown to have higher morbidities when compared with term infants. It is not known if ET infants requiring ECMO for MAS and/or PPHN have higher morbidities and mortality than term infants. Objective of our study was to compare morbidity and mortality in ET infants with MAS and/or PPHN requiring ECMO in comparison to their term counterparts. A total of 3831 neonatal ECMO runs for MAS and/or PPHN were reviewed from the de-identified ELSO registry patient dataset from 2007- 2017. Neonates born at ET (37+0/7 - 38+6/7 weeks) and term (39+0/7 - 40+6/7 weeks) were further classified as two study groups. Both groups were compared using chi-square test. Of 2529 infants who were included in the study, there were 799 ET and 1730 term infants. ET infants when compared with term infants had higher mortality (9.6% vs 6%, P=0.002), lower survival to discharge (80.4% vs 87.7%, P<0.001), higher neurologic complications (14.8% vs 11.5%, P=0.024), and increased need for hemofiltration (32.9% vs 28.7%, P=0.033). There were no statistically significant differences between both groups in hemorrhagic, infectious, metabolic and cardiovascular complications. ET infants with MAS and/or PPHN have higher morbidities and mortality than term infants on ECMO. Caregivers should be informed of higher risks associated with use of ECMO in ET infants when compared to full term newborns
EMBASE:631095453
ISSN: 1538-943x
CID: 4387232

Reply to Letter to the Editor [Letter]

Tomita, Sandra; Fisher, Jason C; Fefferman, Nancy; Ginsburg, Howard B; Kuenzler, Keith A; Choi, Beatrix Hyemin
PMID: 30612745
ISSN: 1531-5037
CID: 3579772

Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant Staphylococcus aureus

Copin, Richard; Sause, William E; Fulmer, Yi; Balasubramanian, Divya; Dyzenhaus, Sophie; Ahmed, Jamil M; Kumar, Krishan; Lees, John; Stachel, Anna; Fisher, Jason C; Drlica, Karl; Phillips, Michael; Weiser, Jeffrey N; Planet, Paul J; Uhlemann, Anne-Catrin; Altman, Deena R; Sebra, Robert; van Bakel, Harm; Lighter, Jennifer; Torres, Victor J; Shopsin, Bo
The past two decades have witnessed an alarming expansion of staphylococcal disease caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). The factors underlying the epidemic expansion of CA-MRSA lineages such as USA300, the predominant CA-MRSA clone in the United States, are largely unknown. Previously described virulence and antimicrobial resistance genes that promote the dissemination of CA-MRSA are carried by mobile genetic elements, including phages and plasmids. Here, we used high-resolution genomics and experimental infections to characterize the evolution of a USA300 variant plaguing a patient population at increased risk of infection to understand the mechanisms underlying the emergence of genetic elements that facilitate clonal spread of the pathogen. Genetic analyses provided conclusive evidence that fitness (manifest as emergence of a dominant clone) changed coincidently with the stepwise emergence of (i) a unique prophage and mutation of the regulator of the pyrimidine nucleotide biosynthetic operon that promoted abscess formation and colonization, respectively, thereby priming the clone for success; and (ii) a unique plasmid that conferred resistance to two topical microbiocides, mupirocin and chlorhexidine, frequently used for decolonization and infection prevention. The resistance plasmid evolved through successive incorporation of DNA elements from non-S. aureus spp. into an indigenous cryptic plasmid, suggesting a mechanism for interspecies genetic exchange that promotes antimicrobial resistance. Collectively, the data suggest that clonal spread in a vulnerable population resulted from extensive clinical intervention and intense selection pressure toward a pathogen lifestyle that involved the evolution of consequential mutations and mobile genetic elements.
PMID: 30635416
ISSN: 1091-6490
CID: 3580072

Simple preoperative radiation safety interventions significantly lower radiation doses during central venous line placement in children

Choi, Beatrix Hyemin; Yaya, Kamalou; Prabhu, Vinay; Fefferman, Nancy; Mitchell, Beverly; Kuenzler, Keith A; Ginsburg, Howard B; Fisher, Jason C; Tomita, Sandra
PURPOSE/OBJECTIVE:The purpose of this study was to reduce radiation exposure during pediatric central venous line (CVL) placement by implementing a radiation safety process including a radiation safety briefing and a job-instruction model with a preradiation time-out. METHODS:We reviewed records of all patients under 21 who underwent CVL placement in the operating room covering 22 months before the intervention through 10 months after 2013-2016. The intervention consisted of a radiation safety briefing by the surgeon to the intraoperative staff before each case and a radiation safety time-out. We measured and analyzed the dose area product (DAP), total radiation time pre- and postintervention, and the use of postprocedural chest radiograph. RESULTS:, P < 0.001) and a 73% decrease in the median radiation time (28 vs 7.6 s, P < 0.001). Additionally, there was a significant reduction in use of confirmatory CXR (95% vs 15%, P < 0.01). CONCLUSION/CONCLUSIONS:A preoperative radiation safety briefing and a radiation safety time-out supported by a job-instruction model were effective in significantly lowering the absorbed doses of radiation in children undergoing CVL insertion. TYPE OF STUDY/METHODS:Case-control study. LEVEL OF EVIDENCE/METHODS:Level III.
PMID: 30415958
ISSN: 1531-5037
CID: 3456542

MINIMIZING ECMO MOBILIZATION TIME FOR BEDSIDE CANNULATIONS BY MAXIMIZING TEAM EFFICIENCY [Meeting Abstract]

Toy, Bridget; Chopra, Arun; Cicalese, Erin; Dapul, Heda; Verma, Sourabh; Fisher, Jason
ISI:000498593401663
ISSN: 0090-3493
CID: 4227752

Morbidity of Conversion from Veno-Venous to Veno-Arterial Extracorporeal Membrane Oxygenation in Neonates with Meconium Aspiration or Persistent Pulmonary Hypertension [Meeting Abstract]

Choi, Beatrix H.; Toy, Bridget; Dapul, Heda; Verma, Sourabh; Cicalese, Erin; Chopra, Arun; Fisher, Jason C.
ISI:000492740900398
ISSN: 1072-7515
CID: 5338662

Simulating nothing: Recreating the mundane to improve ECMO competency [Meeting Abstract]

Toy, B; Dapul, H; Fisher, J; Cicalese, E; Verma, S; Chopra, A
Introduction/Aim: NYU Langone Health's first neonatal ECMO patient was in March 2015, marking the start of the Pediatric and Neonatal ECMO Program within the institution. Since then, our program averages 5 ECMO patients per fiscal year (September 1 to August 31). A core ECMO Team, consisting of a Medical Director, a Surgical Director, an ECMO coordinator, 2 Chiefs of Perfusion, and 3 ECMO Intensivists, was identified to establish a reservoir of ECMO expertise within our new, low volume ECMO program. When a patient requires ECMO support, the core ECMO Team collaborates with the multidisciplinary ICU team to optimize both patient and circuit management. The teams provide concurrent care with the ECMO Team overseeing all ECMO-related decision making. Despite having the core ECMO Team as a resource during each ECMO case, a low volume of ECMO patients per year augments slower institutional learning and highlights the need for more frequent educational opportunities. The core ECMO Team worked together to create a recurring multidisciplinary Pediatric ECMO In-situ Simulation to bridge the educational gap in a new, low volume ECMO center. Material and Methods: The goal of establishing Pediatric ECMO In-Situ Simulation was to have either a real life patient on ECMO support or have a simulated ECMO patient once a month to establish routine ECMO exposure and promote multidisciplinary learning and competency. The first simulation session took place in September 2017. For 9 consecutive months, we achieved this goal with 4 real life ECMO patients and 5 simulated ECMO patients. Each simulation session took place over 4 hours and included a complete critical care team, consisting of an ICU Attending Physician, an Advanced Practice Provider, a Resident, 2 Critical Care Nurses, a Perfusionist, and a Respiratory Therapist. Pre-and postsimulation, participants completed self-assessments and knowledge tests, which were then, analyzed using the Wilcoxon Signed-rank test. Simulation logistics included a high fidelity simulation mannequin that was connected to a running ECMO circuit, as well as IV infusions and a mechanical ventilator. Simulation medications, fluids, blood products, and bedside supplies were readily available for the participants. Contact information to simulated ancillary departments, such as Inpatient STAT Lab, Blood Bank and Radiology, was distributed. We also collaborated with Hospital Informatics to create a virtual medical record for the simulated patient, which allowed the participants to view the ECMO order set, lab values, imaging results, vital signs, etc. The participants could also place orders in real time and document in the "patient's" medical record. The primary learning objective of the simulation was to improve competency in the daily management of an ECMO patient with less emphasis on ECMO circuit troubleshooting and emergency management. Scenarios included routine ECMO practices, such as conducting multidisciplinary ECMO rounds, adhering to programmatic processes, completing hourly patient assessments and documentation requirements, and monitoring patient fluid volume status. Results: 27 participants took pre-and post-course tests to assess their ECMO knowledge. They also filled out pre-and post-course selfassessments to determine their level of self-confidence in caring for an ECMO patient. One participant was excluded from the data analysis due to incomplete test scores and survey responses. Using the Wilcoxon Signed-rank test, we found a statistically significant improvement in the self-assessment scores (p=0.00001284). There was also a trend towards improvement in the knowledge scores (p=0.09). Conclusions: High fidelity in-situ simulation targeting various learner groups is effective with improvement in self-confidence and written knowledge. Recurring simulation opportunities in a new, low volume ECMO Center promotes continued familiarity and experience in caring for ECMO patients. Next steps include conducting multiple simulation sessions throughout a longer time span, such as over a 12 to 24 hour period
EMBASE:624562111
ISSN: 1538-943x
CID: 3430602

The impact of a structured ECMO program in a low volume ECMO center [Meeting Abstract]

Toy, B; Verma, S; Fisher, J; Cicalese, E; Dapul, H; Chopra, A
Introduction/Aim: Our Pediatric ECMO Program was launched in March of 2015. Based on historical volumes and projections we anticipated a low volume center. Per ELSO Guidelines, ECMO centers require institutional structure and organization for effective use of ECMO therapy. Also, literature review of pediatric ECMO patient outcomes imply that high volume ECMO centers are associated with improved survival rates in pediatric ECMO patients. Our goal was to implement a formal Pediatric ECMO Program, along with a structured educational course, to demonstrate that successful patient survival rates are obtainable in a low volume ECMO center. Material and Methods: A comprehensive review was completed to identify gaps and areas for improvement within the current state of ECMO at the institution with the goal of establishing an ECMO Program, per ELSO Guidelines, that ensures safe use of ECMO, improved patient outcomes, and optimized programmatic processes. Interventions implemented to formalize the ECMO Program included establishment of clinical practice guidelines and protocols, creation of an ECMO credentialing process, standardization of intrahospital processes related to ECMO, and organization of patient data collection. To assure reasonable use of this resource all cannulation and decannulation decisions required agreement of both the Medical and Surgical ECMO Directors. Formalization of the interprofessional collaboration with the critical care teams and ancillary departments was established with structured morning and evening rounds. Collaboration continued through implementation of formal multidisciplinary team meetings, including patient case reviews and quality assurance meetings. Last, a primary intervention in formalization of an ECMO Program was the establishment of an ECMO education course that was required for all providers who would be involved in the care of ECMO patients. The course was geared towards frontline critical care physicians and advanced practice providers caring for pediatric ECMO patients. The course included didactic learning and simulation training with a high fidelity simulation mannequin and a running ECMO circuit. Pre-and postcourse, participants completed self-assessments and knowledge tests. Results: Since March 2015, our Pediatric ECMO Program averages 5 ECMO patients per fiscal year (September 1 to August 31). In the first fiscal year (FY) 2015, our survival from ECMO rate was 33% with 0% of our patients surviving to discharge. Our hemorrhagic and neurologic complication rates were 67%. The formalization of our ECMO Program and implementation of ECMO education occurred in April 2016, mid FY 2016. Our survival from ECMO rate for FY 2016 improved from 33% to 86%, showing a 160.6% increase. Subsequently, our survival from ECMO rates continued to improve with FY 2017 having 100% survival rate and FY 2018 having 80% survival rate. We also observed a notable decrease in hemorrhagic and neurologic complications per FY. These complications decreased by 40.3% and 70.1%, respectively. Along with tracking our ECMO patient outcomes and complications, our program closely monitors our ECMO consults. Since March 2015, we average 23 ECMO consults per FY with an average of 5 patients (20%) placed on ECMO and 18 patients (80%) denied from ECMO. Out of the patients who were denied ECMO support, 30% of patients expired and 70% of patients recovered and survived to discharge, emphasizing the importance of strict patient selection criteria and centralized ECMO decision-making. For our ECMO course results, our team has held seven courses since August 2016. Among the first time participants (n=82), 84% showed improvement, 10% did worse, and 6% had incomplete data in their post-test written knowledge test. Conclusions: Despite a low institutional case volume of ECMO patients, creation of a structured ECMO Program with a recurring comprehensive ECMO course, promotes both self-confidence and clinical abilities of the multidisciplinary critical care team, as well as improves patient outcomes. Ongoing data collection and quality improvement will be essential to maintain this high level of performance
EMBASE:624562114
ISSN: 1538-943x
CID: 3430592

Ultrasound Has Limited Utility in the Surgical Management of Geographically Clustered Pediatric MRSA Infections [Meeting Abstract]

Ramaraj, Akila; Lighter-Fisher, Jennifer; Shopsin, Bo; Stachel, Anna; Rosenberg, Rebecca E; Chopra, Arun; Kuenzler, Keith A; Tomita, Sandra S; Ginsburg, Howard B; Fisher, Jason C
ISI:000413315300337
ISSN: 1879-1190
CID: 2767602

Increased capture of pediatric surgical complications utilizing a novel case-log web application to enhance quality improvement

Fisher, Jason C; Kuenzler, Keith A; Tomita, Sandra S; Sinha, Prashant; Shah, Paresh; Ginsburg, Howard B
PURPOSE: Documenting surgical complications is limited by multiple barriers and is not fostered in the electronic health record. Tracking complications is essential for quality improvement (QI) and required for board certification. Current registry platforms do not facilitate meaningful complication reporting. We developed a novel web application that improves accuracy and reduces barriers to documenting complications. METHODS: We deployed a custom web application that allows pediatric surgeons to maintain case logs. The program includes a module for entering complication data in real time. Reminders to enter outcome data occur at key postoperative intervals to optimize recall of events. Between October 1, 2014, and March 31, 2015, frequencies of surgical complications captured by the existing hospital reporting system were compared with data aggregated by our application. RESULTS: 780 cases were captured by the web application, compared with 276 cases registered by the hospital system. We observed an increase in the capture of major complications when compared to the hospital dataset (14 events vs. 4 events). CONCLUSIONS: This web application improved real-time reporting of surgical complications, exceeding the accuracy of administrative datasets. Custom informatics solutions may help reduce barriers to self-reporting of adverse events and improve the data that presently inform pediatric surgical QI. TYPE OF STUDY: Diagnostic study/Retrospective study. LEVEL OF EVIDENCE: Level I
PMID: 27856010
ISSN: 1531-5037
CID: 2311002